Peter S Kim insider trades
Open-market stock purchases and sales by Peter S Kim, Director at Entrada Therapeutics, Inc, from SEC Form 4 filings since Jan 8, 2010.
Track record: 0% of 13 scored buys are up 5% or more since purchase, averaging -48%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | TRDA Entrada Therapeutics, Inc | Bought (not open market) | — |